Human genetic factors in tuberculosis: an update

Tropical Medicine and International Health

Volumn 22, Issue 9, 2017, Pages 1063-1071

  van Tong, Hoang ^a,b   Velavan, Thirumalaisamy P ^a,c   Thye, Thorsten ^d   Meyer, Christian G ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^c DUY TAN UNIVERSITY   (Viet Nam)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

candidate gene studies; genome wide association studies; human genetics; tuberculosis

Indexed keywords

HOST FACTOR; TOLL LIKE RECEPTOR; VITAMIN D RECEPTOR;

BACTERIUM; DATABASE; DEVELOPING WORLD; DISEASE RESISTANCE; GENETIC ANALYSIS; GENETIC VARIATION; GENETICS; GENOME; HOST; POLYMORPHISM; PUBLIC HEALTH; TUBERCULOSIS; VULNERABILITY;

COEVOLUTION; DNA POLYMORPHISM; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HEREDITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN GENETICS; INFORMATION RETRIEVAL; MEDLINE; REVIEW; SYSTEMATIC REVIEW; TUBERCULOSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; TUBERCULOSIS;

EID: 85025066643     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12923     Document Type: Review

References (78)

1. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009: 27: 393–422.
2. Simonds B. Twin research in tuberculosis. Eugen Rev 1957: 49: 25–32.
3. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978: 117: 621–624.
4. Jorgensen TJ, Ruczinski I, Kessing B, Smith MW, Shugart YY, Alberg AJ. Hypothesis-driven candidate gene association studies: practical design and analytical considerations. Am J Epidemiol 2009: 170: 986–993.
5. Meyer CG, Thye T. Host genetic studies in adult pulmonary tuberculosis. Semin Immunol 2014: 26: 445–453.
6. Thye T, Meyer CG. Human genetic variability and susceptibility to pulmonary TB. Tuberculosis. Eur Respir Monogr 2012: 58: 38–58.
7. Saraav I, Singh S, Sharma S. Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response or immune evasion? Immunol Cell Biol 2014: 92: 741–746.
8. Gopalakrishnan A, Salgame P. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question. Curr Opin Immunol 2016: 42: 76–82.
9. Zhang Y, Jiang T, Yang X et al. Toll-like receptor -1, -2, and -6 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis. PLoS ONE 2013: 8: e63357.
10. Medvedev AE. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer. J Interferon Cytokine Res 2013: 33: 467–484.
11. Netea MG, Wijmenga C, O'Neill LA. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 2012: 13: 535–542.
12. Salie M, Daya M, Lucas LA et al. Association of toll-like receptors with susceptibility to tuberculosis suggests sex-specific effects of TLR8 polymorphisms. Infect Genet Evol 2015: 34: 221–229.
13. Bukhari M, Aslam MA, Khan A et al. TLR8 gene polymorphism and association in bacterial load in southern Punjab of Pakistan: an association study with pulmonary tuberculosis. Int J Immunogenet 2015: 42: 46–51.
14. Dittrich N, Berrocal-Almanza LC, Thada S et al. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis. Tuberculosis 2015: 95: 328–335.
15. Bhanothu V, Lakshmi V, Theophilus JP, Rozati R, Badhini P, Vijayalaxmi B. Investigation of Toll-like receptor-2 (2258G/A) and interferon gamma (+874T/A) gene polymorphisms among infertile women with female genital tuberculosis. PLoS ONE 2015: 10: e0130273.
16. Rizvi I, Garg RK, Jain A et al. Vitamin D status, vitamin D receptor and toll like receptor-2 polymorphisms in tuberculous meningitis: a case-control study. Infection 2016: 44: 633–640.
17. Zhao Y, Bu H, Hong K et al. Genetic polymorphisms of CCL1 rs2072069 G/A and TLR2 rs3804099 T/C in pulmonary or meningeal tuberculosis patients. Int J Clin Exp Pathol 2015: 8: 12608–12620.
18. Meyer CG, Reiling N, Ehmen C et al. TLR1 variant H305L associated with protection from pulmonary tuberculosis. PLoS ONE 2016: 11: e0156046.
19. Wu L, Hu Y, Li D, Jiang W, Xu B. Screening toll-like receptor markers to predict latent tuberculosis infection and subsequent tuberculosis disease in a Chinese population. BMC Med Genet 2015: 16: 19.
20. Graustein AD, Horne DJ, Arentz M et al. TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam. Tuberculosis 2015: 95: 190–196.
21. Jafari M, Nasiri MR, Sanaei R et al. The NRAMP1, VDR, TNF-alpha, ICAM1, TLR2 and TLR4 gene polymorphisms in Iranian patients with pulmonary tuberculosis: A case-control study. Infect Genet Evol 2016: 39: 92–98.
22. Bulat-Kardum LJ, Etokebe GE, Lederer P, Balen S, Dembic Z. Genetic polymorphisms in the Toll-like receptor 10, interleukin (IL)17A and IL17F genes differently affect the risk for tuberculosis in Croatian population. Scand J Immunol 2015: 82: 63–69.
23. Aranow C. Vitamin D and the immune system. J Investig Med 2011: 59: 881–886.
24. Facchini L, Venturini E, Galli L, de Martino M, Chiappini E. MM, E. Vitamin D and tuberculosis: a review on a hot topic. J Chemother 2015: 27: 128–138.
25. Keflie TS, Nolle N, Lambert C, Nohr D, Biesalski HK. Vitamin D deficiencies among tuberculosis patients in Africa: a systematic review. Nutrition 2015: 31: 1204–1212.
26. Cao Y, Wang X, Cao Z, Cheng X. Association of Vitamin D receptor gene TaqI polymorphisms with tuberculosis susceptibility: a meta-analysis. Int J Clin Exp Med 2015: 8: 10187–10203.
27. Huang L, Liu C, Liao G, Yang X, Tang X, Chen J. Vitamin D receptor gene FokI polymorphism contributes to increasing the risk of tuberculosis: an update meta-analysis. Medicine (Baltimore) 2015: 94: e2256.
28. Lee YH, Song GG. Vitamin D receptor gene FokI, TaqI, BsmI, and ApaI polymorphisms and susceptibility to pulmonary tuberculosis: a meta-analysis. Genet Mol Res 2015: 14: 9118–9129.
29. Lee SW, Chuang TY, Huang HH, Liu CW, Kao YH, Wu LS. VDR and VDBP genes polymorphisms associated with susceptibility to tuberculosis in a Han Taiwanese population. J Microbiol Immunol Infect 2016: 49: 783–787.
30. Rashedi J, Asgharzadeh M, Moaddab SR et al. Vitamin d receptor gene polymorphism and vitamin d plasma concentration: correlation with susceptibility to tuberculosis. Adv Pharm Bull 2014: 4(Suppl 2): 607–611.
31. Cao Y, Wang X, Cao Z, Cheng X. Vitamin D receptor gene FokI polymorphisms and tuberculosis susceptibility: a meta-analysis. Arch Med Sci 2016: 12: 1118–1134.
32. Harishankar M, Selvaraj P. Regulatory role of Cdx-2 and Taq I polymorphism of vitamin D receptor gene on chemokine expression in pulmonary tuberculosis. Hum Immunol 2016: 77: 498–505.
33. Torres-Juarez F, Cardenas-Vargas A, Montoya-Rosales A et al. LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages. Infect Immun 2015: 83: 4495–4503.
34. Larcombe L, Mookherjee N, Slater J et al. Vitamin D, serum 25(OH)D, LL-37 and polymorphisms in a Canadian First Nation population with endemic tuberculosis. Int J Circumpolar Health 2015: 74: 28952.
35. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993: 178: 2249–2254.
36. Shin JG, Park BL, Kim LH et al. Association study of polymorphisms in interferon-gamma receptor genes with the risk of pulmonary tuberculosis. Mol Med Rep 2015: 12: 1568–1578.
37. Meyer CG, Intemann CD, Forster B et al. No significant impact of IFN-gamma pathway gene variants on tuberculosis susceptibility in a West African population. Eur J Hum Genet 2016: 24: 748–755.
38. Hijikata M, Matsushita I, Le Hang NT et al. Influence of the polymorphism of the DUSP14 gene on the expression of immune-related genes and development of pulmonary tuberculosis. Genes Immun 2016: 17: 207–212.
39. Miao R, Ge H, Xu L et al. Genetic variants at 18q11.2 and 8q24 identified by genome-wide association studies were not associated with pulmonary tuberculosis risk in Chinese population. Infect Genet Evol 2016: 40: 214–218.
40. Lee SW, Lin CY, Chuang TY, Huang HH, Kao YH, Wu LS. SNP rs4331426 in 18q11.2 is associated with susceptibility to tuberculosis among female Han Taiwanese. J Microbiol Immunol Infect 2016: 49: 436–438.
41. Braun K, Wolfe J, Kiazyk S, Kaushal SM. Evaluation of host genetics on outcome of tuberculosis infection due to differences in killer immunoglobulin-like receptor gene frequencies and haplotypes. BMC Genet 2015: 16: 63.
42. Du J, Han J, Li X, Zhang Y, Li H, Yang S. StIL-17 gene polymorphisms in the development of pulmonary tuberculosis. Int J Clin Exp Pathol 2015: 8: 3225–3229.
43. Zhao J, Wen C, Li M. Association analysis of interleukin-17 gene polymorphisms with the risk susceptibility to tuberculosis. Lung 2016: 194: 459–467.
44. Qrafli M, Amar Y, Bourkadi J et al. The CYP7A1 gene rs3808607 variant is associated with susceptibility of tuberculosis in Moroccan population. Pan Afr Med J 2014: 18: 1.
45. Yi YX, Han JB, Zhao L, Fang Y, Zhang YF, Zhou GY. Tumor necrosis factor alpha gene polymorphism contributes to pulmonary tuberculosis susceptibility: evidence from a meta-analysis. Int J Clin Exp Med 2015: 8: 20690–20700.
46. Yi L, Zhang K, Mo Y, Zhen G, Zhao J. The association between CD209 gene polymorphisms and pulmonary tuberculosis susceptibility: a meta-analysis. Int J Clin Exp Pathol 2015: 8: 12437–12445.
47. Yuan L, Ke Z, Ma J, Guo Y, Li Y. IRGM gene polymorphisms and haplotypes associate with susceptibility of pulmonary tuberculosis in Chinese Hubei Han population. Tuberculosis 2016: 96: 58–64.
48. Thuong NT, Dunstan SJ, Chau TT et al. Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog 2008: 4: e1000229.
49. Nonghanphithak D, Reechaipichitkul W, Namwat W, Lulitanond V, Naranbhai V, Faksri K. Genetic polymorphisms of CCL2 associated with susceptibility to latent tuberculous infection in Thailand. Int J Tuberc Lung Dis 2016: 20: 1242–1248.
50. Kouhpayeh HR, Taheri M, Baziboroon M, Naderi M, Bahari G, Hashemi M. CCL5 rs2107538 polymorphism increased the risk of tuberculosis in a sample of Iranian population. Prague Med Rep 2016: 117: 90–97.
51. Azar AF, Jazani NH, Bazmani A, Vahhabi A, Shahabi S. Polymorphisms in beta-2 adrenergic receptor gene and association with tuberculosis. Lung 2017: 195: 147–153.
52. Liu Q, Wu S, Xue M et al. Heterozygote advantage of the rs3794624 polymorphism in CYBA for resistance to tuberculosis in two Chinese populations. Sci Rep 2016: 6: 38213.
53. Naderi M, Hashemi M, Abedipour F, Bahari G, Rezaei M, Taheri M. Evaluation of interferon-induced transmembrane protein-3 (IFITM3) rs7478728 and rs3888188 polymorphisms and the risk of pulmonary tuberculosis. Biomed Rep 2016: 5: 634–638.
54. Seshadri C, Thuong NT, Mai NT et al. A polymorphism in human MR1 is associated with mRNA expression and susceptibility to tuberculosis. Genes Immun 2017: 18: 8–14.
55. Zhang S, Wang XB, Han YD, Wang C, Zhou Y, Zheng F. Certain polymorphisms in SP110 gene confer susceptibility to tuberculosis: a comprehensive review and updated meta-analysis. Yonsei Med J 2017: 58: 165–173.
56. Thye T, Vannberg FO, Wong SH et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010: 42: 739–741.
57. Thye T, Owusu-Dabo E, Vannberg FO et al. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet 2012: 44: 257–259.
58. Curtis J, Luo Y, Zenner HL et al. Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration. Nat Genet 2015: 47: 523–527.
59. Hu X, Peng W, Chen X et al. No significant effect of ASAP1 gene variants on the susceptibility to tuberculosis in Chinese population. Medicine (Baltimore) 2016: 95: e3703.
60. Grant AV, Sabri A, Abid A et al. A genome-wide association study of pulmonary tuberculosis in Morocco. Hum Genet 2016: 135: 299–307.
61. Sobota RS, Stein CM, Kodaman N et al. A locus at 5q33.3 confers resistance to tuberculosis in highly susceptible individuals. Am J Hum Genet 2016: 98: 514–524.
62. Wang Y, Yan XY, Wu JC et al. Analysis of silent information regulator 1 (SIRT1) gene polymorphisms in antituberculosis- drug-induced hepatotoxicity in a prospective cohort study. Int J Clin Pharmacol Ther 2016: 54: 775–781.
63. Hennig S, Naiker S, Reddy T et al. Effect of SLCO1B1 polymorphisms on rifabutin pharmacokinetics in African HIV-infected patients with tuberculosis. Antimicrob Agents Chemother 2015: 60: 617–620.
64. Weiner M, Peloquin C, Burman W et al. Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations. Antimicrob Agents Chemother 2010: 54: 4192–4200.
65. Chigutsa E, Visser ME, Swart EC et al. The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications. Antimicrob Agents Chemother 2011: 55: 4122–4127.
66. Petros Z, Lee MM, Takahashi A et al. Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity. BMC Genom 2016: 17: 755.
67. Perwitasari DA, Irham LM, Darmawan E, Mulyani UA, Atthobari J. CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients. Indian J Tuberc 2016: 63: 139–143.
68. Gagneux S, DeRiemer K, Van T et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006: 103: 2869–2873.
69. Brites D, Gagneux S. Co-evolution of Mycobacterium tuberculosis and Homo sapiens. Immunol Rev 2015: 264: 6–24.
70. Coscolla M, Gagneux S. Consequences of genomic diversity in Mycobacterium tuberculosis. Semin Immunol 2014: 26: 431–444.
71. Warner DF, Koch A, Mizrahi V. Diversity and disease pathogenesis in Mycobacterium tuberculosis. Trends Microbiol 2015: 23: 14–21.
72. Hershberg R, Lipatov M, Small PM et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 2008: 6: e311.
73. Comas I, Chakravartti J, Small PM et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010: 42: 498–503.
74. Copin R, Wang X, Louie E et al. Within host evolution selects for a dominant genotype of Mycobacterium tuberculosis while T cells increase pathogen genetic diversity. PLoS Pathog 2016: 12: e1006111.
75. Caws M, Thwaites G, Dunstan S et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008: 4: e1000034.
76. Thye T, Niemann S, Walter K et al. Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis. PLoS ONE 2011: 6: e20908.
77. Intemann CD, Thye T, Niemann S et al. Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog 2009: 5: e1000577.
78. Salie M, van der Merwe L, Moller M et al. Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease. J Infect Dis 2014: 209: 216–223.